The US market is becoming less expensive, with high-quality companies appearing undervalued. Morningstar’s “Best Companies to Own” list highlights firms with strong competitive advantages. The focus now is on the 10 best companies with undervalued stock prices, offering potential investment opportunities in January 2026.

Among the 10 most undervalued stocks are Campbell’s, Coloplast, Clorox, Yum China, Constellation Brands, Zimmer Biomet, Tyler Technologies, Ambev, Diageo, and Dassault Systèmes. These companies exhibit promising metrics and are trading below their fair value estimates as of December 30, 2025, presenting attractive investment options.

Campbell’s, the most undervalued stock, boasts a wide Economic Moat Rating and strategic cost-saving plans. Coloplast leads in ostomy and continence care, with a strong innovation track record. Clorox excels in consumer products, focusing on innovation and e-commerce. Yum China sees growth opportunities in the Chinese fast-food industry. Constellation Brands dominates the US alcoholic beverages market.

Zimmer Biomet is a leader in large-joint reconstruction, with strong customer loyalty. Tyler Technologies dominates the government operational software market. Ambev holds a monopoly in Latin America’s beer markets, ensuring market share through cost advantages. Diageo is a global spirits leader focusing on premiumization. Dassault Systèmes leads in computer-assisted design software, with a strong hold on the engineering sector.

Read more at Morningstar: The 10 Best Companies to Invest in Now